Recombinant adeno-associated viral vectors as therapeutic agents to treat neurological disorders
Authors:
- Ronald J. MandelRMRonald J. Mandel
- Fredric P. ManfredssonFMFredric P. Manfredsson
- Kevin D. FoustKFKevin D. Foust
- Aaron RisingARAaron Rising
- Sharon ReimsniderSRSharon Reimsnider
- Kevin NashKNKevin Nash
- Corinna BurgerCBCorinna Burger
Open Access
- 1 March 2006
- journal article
- review article
- Published by Elsevier in Molecular Therapy
- Vol. 13 (3) , 463-483
Abstract
No abstract availableKeywords
This publication has 215 references indexed in Scilit:
- Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic miceMolecular Therapy, 2005
- Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan diseaseMolecular Therapy, 2005
- AAV-Mediated expression of galactocerebrosidase in brain results in attenuated symptoms and extended life span in murine models of globoid cell leukodystrophyMolecular Therapy, 2005
- Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factorExperimental Neurology, 2004
- RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxiaNature Medicine, 2004
- AAV-Mediated gene delivery of BDNF or GDNF is neuroprotective in a model of huntington diseaseMolecular Therapy, 2004
- Neuropathological and Behavioral Consequences of Adeno-Associated Viral Vector-Mediated Continuous Intrastriatal Neurotrophin Delivery in a Focal Ischemia Model in RatsNeurobiology of Disease, 2002
- Functional Effect of Adeno-associated Virus Mediated Gene Transfer of Aromatic L-Amino Acid Decarboxylase into the Striatum of 6-OHDA-Lesioned RatsMolecular Therapy, 2001
- Huntington's disease: CAG genetics expands neurobiologyCurrent Opinion in Neurobiology, 1995
- Continuous and intermittent levodopa differentially affect basal ganglia functionAnnals of Neurology, 1989